Cumberland Pharmaceuticals Correlations

CPIX Stock  USD 4.33  0.07  1.59%   
The correlation of Cumberland Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cumberland Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Cumberland Pharmaceuticals and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Moving together with Cumberland Stock

  0.78AZN AstraZeneca PLC ADRPairCorr
  0.74LLY Eli LillyPairCorr
  0.68OCX OncoCyte CorpPairCorr
  0.7SNY Sanofi ADRPairCorr
  0.81GILD Gilead SciencesPairCorr
  0.73GOSS Gossamer BioPairCorr
  0.79AMGN Amgen IncPairCorr

Moving against Cumberland Stock

  0.82IMRX Immuneering CorpPairCorr
  0.77IMMX Immix BiopharmaPairCorr
  0.75VINC Vincerx Pharma Earnings Call TomorrowPairCorr
  0.73MLTX MoonLake ImmunotherapeutiPairCorr
  0.7ZURA Zura Bio LimitedPairCorr
  0.66MRK Merck CompanyPairCorr
  0.64GPCR Structure TherapeuticsPairCorr
  0.58ZVSA ZyVersa TherapeuticsPairCorr
  0.53CDIOW Cardio DiagnosticsPairCorr
  0.53ELVN Enliven TherapeuticsPairCorr
  0.48ELEV Elevation OncologyPairCorr
  0.83PYXS Pyxis OncologyPairCorr
  0.8SCLX Scilex HoldingPairCorr
  0.76ASMB Assembly Biosciences Downward RallyPairCorr
  0.73CGEM Cullinan Oncology LLCPairCorr
  0.73CMND Clearmind Medicine CommonPairCorr
  0.69AVTE Aerovate TherapeuticsPairCorr
  0.68RAIN Rain Enhancement TecPairCorr
  0.67ATNF 180 Life SciencesPairCorr
  0.66CNSP Cns Pharmaceuticals Earnings Call This WeekPairCorr
  0.53SONN Sonnet BiotherapeuticsPairCorr
  0.52PHIO Phio Pharmaceuticals Corp Earnings Call This WeekPairCorr
  0.51CRNX Crinetics PharmaceuticalsPairCorr
  0.5PMVP Pmv PharmaceuticalsPairCorr
  0.49BIIB Biogen IncPairCorr
  0.4CDIO Cardio DiagnosticsPairCorr
  0.4CELC Celcuity LLCPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SHPHPTPI
SHPHIXHL
PTPIIXHL
PTPIPROC
EVOKIXHL
SHPHPROC
  
High negative correlations   
EVOKRGC
IXHLRGC
SHPHRGC
PRFXRGC
PTPIRGC
PROCRGC

Risk-Adjusted Indicators

There is a big difference between Cumberland Stock performing well and Cumberland Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cumberland Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
EGRX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RGC  13.48  6.06  0.75 (0.71) 5.76 
 46.25 
 265.55 
PROC  6.35  0.04  0.00  0.00  8.25 
 7.98 
 96.00 
IXHL  4.37 (1.33) 0.00  2.72  0.00 
 8.33 
 30.31 
PTPI  8.92  0.10  0.01  0.02  10.98 
 14.29 
 72.24 
EVOK  3.20 (0.74) 0.00 (0.70) 0.00 
 6.85 
 30.53 
AGRX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PRFX  4.58 (0.85) 0.00 (0.48) 0.00 
 6.69 
 40.81 
SHPH  4.54 (0.96) 0.00 (5.52) 0.00 
 9.41 
 28.76 
MNK  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Cumberland Pharmaceuticals Corporate Management

James HermanChief Compliance Officer and VP of National AccountsProfile
John HammChief OfficerProfile
Christophe BittermanVice MarketingProfile
Todd AnthonyVice DevelopmentProfile
Adam MostafaManaging RelationsProfile
Erin GullSenior AssociateProfile